K

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Senior Director - Clinical Pharmacology

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeLexington, MA, USA$221k - $250kHybrid

About the Job

Requirements

  • Proven expertise in developing and implementing clinical pharmacology and modeling and simulation strategies for large molecules and biologics, including familiarity with pharmacokinetic and pharmacodynamic complexities such as immunogenicity, antibody-drug conjugates, ligand traps, and target-mediated drug disposition.
  • Hands-on proficiency with standard industry modeling and simulation software platforms such as Phoenix WinNonlin is required.
  • Secondary familiarity with SAS, Python, Julia, or MATLAB is highly valued.
  • A solid history of authoring regulatory submission documents, including New Drug Applications, Biologics License Applications, and Marketing Authorization Applications, with direct experience defending dosing strategies and data packages to global health authorities.
  • In-depth knowledge of regulatory requirements related to clinical pharmacology, modeling and simulation, and drug development.
  • Strong written and verbal communication abilities, including explaining complex quantitative data to non-modeling colleagues and executive leadership teams.
  • Ability to work effectively and collaboratively on cross-functional teams.
  • Strong project management skills and the ability to prioritize and manage multiple projects simultaneously.
  • Experience managing external vendors is required.
  • An advanced degree (Ph.D., Pharm.D., or M.D.) in Pharmaceutical Sciences, Pharmacokinetics, Pharmacology, Pharmacometrics, or a highly quantitative scientific discipline is required.
  • At least 8 to 10+ years of direct pharmaceutical or biotechnology industry experience specializing in clinical pharmacology, pharmacometrics, and drug development, with a track record of increasing leadership responsibility.

Responsibilities

  • Define, champion, and execute global clinical pharmacology and quantitative modeling and simulation strategies for small molecules and biologics from pre-IND and first-in-human through Phase 2/3 and global marketing submissions.
  • Serve as the clinical pharmacology subject matter expert on cross-functional program teams and influence pipeline and clinical development strategy through quantitative logic and modeling frameworks.
  • Independently perform and oversee fitness-for-purpose quantitative analyses, including non-compartmental analysis, population pharmacokinetics, pharmacokinetic/pharmacodynamic analyses, exposure-response analyses, and clinical trial simulations, to answer critical development questions.
  • Direct the design, execution, analysis, interpretation, and reporting of dedicated clinical pharmacology protocols, including human ADME, drug-drug interactions, food-effect, bioavailability/bioequivalence, and special-population studies such as renal or hepatic impairment.
  • Author, review, and defend clinical pharmacology components of regulatory dossiers, including INDs, investigator brochures, CTAs, NDAs, BLAs, MAAs, briefing documents, and response panels; represent Keros in face-to-face interactions with health authorities such as the FDA and EMA.
  • Build cross-functional partnerships with internal stakeholders across DMPK, Toxicology, Biology, Translational Medicine, Biometrics, Regulatory Affairs, Clinical Operations, and CMC.
  • Select, onboard, and manage external contract research organizations and strategic pharmacometrics vendors to ensure high-quality, timely deliverables within budget targets.
  • Lead the continuous optimization of internal clinical pharmacology and modeling and simulation platforms by identifying, evaluating, and adopting advanced computational tools, analytical methodologies, and departmental standard operating procedures.
  • Supervise, mentor, and develop junior scientists and quantitative modelers through direct reporting lines and matrixed project structures.

Desired Qualifications

  • Prior background or deep scientific familiarity with neuromuscular or neurodegenerative disease areas is strongly preferred.
  • Familiarity with SAS, Python, Julia, or MATLAB is highly valued.

About the Company

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.

Company size
51-200
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Keros Therapeutics

See more jobs